Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
ARA-290 received FDA Orphan Drug and Fast Track designations (development incentives, not approvals), but no NDA was submitted and development stalled after Phase 2
Consequently, users should prioritize consistent and measured dosing to maximize benefits
Neurosci Lett 142:128130 Jensen GE, Clausen J (1984) Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis
Investigators working in cell-culture protocols frequently prepare stock solutions in sterile water at 110 mg/mL and then dilute into culture medium to working concentrations
US$ 28.16
US$ 23.95
US$ 26.71
US$ 22.04
US$ 29.24
